Edward Lubin, MD
Pain Medicine · Tampa, FLNPI 1508834706
Payments from drug & device makers
Across 123 payments — averaging $37.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$848
- Nalu Medical, Inc.$801
- Alevio, LLC$784
- Boston Scientific$399
- Painteq LLC$301
- AbbVie$209
- plus $1K from 18 others
What the payments were for
- Consulting fees$90920%
- Travel & lodging$4089%
- Food & beverage$3,27071%
- Education$210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 23 | $848 |
| Nalu Medical, Inc. | 14 | $801 |
| Alevio, LLC | 1 | $784 |
| Boston Scientific | 14 | $399 |
| Painteq LLC | 10 | $301 |
| AbbVie(2 entities) | 6 | $209 |
| Vertos Medical, Inc. | 13 | $184 |
| Stimwave Technologies Incorporated | 2 | $183 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $162 |
| Medtronic(2 entities) | 2 | $117 |
| Relievant Medsystems, Inc. | 6 | $102 |
| Si-bone, Inc. | 3 | $87 |
| Pfizer | 3 | $72 |
| Globus Medical | 3 | $65 |
| Bioventus LLC | 3 | $52 |
| Integra Lifesciences Corporation | 1 | $40 |
| Spinal Simplicity, LLC | 2 | $39 |
| Hikma Pharmaceuticals USA | 2 | $39 |
| Coastal Medical Technologies LLC | 2 | $38 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Nevro Corp. | 1 | $22 |
| Curonix LLC | 1 | $15 |
| Saluda Medical Americas, Inc. | 1 | $15 |
| Foundation Fusion Solutions, LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SICURE SACROILIAC JOINT FUSION SYSTEM$784
- Nalu Neurostimulation System$540
- Proclaim Family of SCS IPGs$283
- PAINTEQ$192
- PROCLAIM$141
- StimQ Receiver Stimulator Kit Channel A US w Receiver$138
- StimQ Freedom-4A Receiver Kit Channel A US w/ Receiver$138
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$138
- Freedom 4A Receiver Kit Channel A US w Receiver$138
- Freedom 8A Receiver Kit Channel A US w Receiver$138
- BOTOX$125
How this compares
$4,608 in reported general payments places this provider in the 60th percentile of 596 pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 183 | $115,503 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,293 | $47,243 |
| RelistorMethylnaltrexone Bromide | 15 | $36,588 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,157 | $32,411 |
| Oxycodone Hcl | 951 | $16,197 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 72 | $15,760 |
| Morphine Sulfate ErMorphine Sulfate | 572 | $13,503 |
| Naloxone Hcl | 174 | $13,152 |
| Nucynta ErTapentadol Hcl | 13 | $12,113 |
| MovantikNaloxegol Oxalate | 26 | $11,445 |
| ZubsolvBuprenorphine Hcl/Naloxone Hcl | 15 | $10,661 |
| BelbucaBuprenorphine Hcl | 20 | $10,604 |
| Pregabalin | 389 | $7,554 |
| Lidocaine | 96 | $6,744 |
| OxycontinOxycodone Hcl | 13 | $6,409 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta Er, Belbuca | $23 | $138,220216 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $162 | $36,58815 claims |
| Hikma Pharmaceuticals USABuprenorphine-Naloxone, Morphine Sulfate, Buprenorphine Hcl | $39 | $20,385216 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 596 pain medicine providers in Florida.
Other pain medicine in Tampa
- Robert GuirguisTampa$895K
- Rodolfo GariTampa$120K
- Edward Podgorski IiiTampa$55K
- Arun KalavaTampa$36K
- Mauricio OrbegozoTampa$31K
- Jorge LealTampa$30K
- Abraham RiveraTampa$27K
- Charles BrockTampa$26K
- Anand PatelOrmond Beach$20.4M
- Julio PaezClermont$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.